Anthem Inc. Announces Changes to its Leadership Team | Business


Anthem, Inc. (NYSE: ANTM) today announced organizational changes within the leadership team, reflecting the company’s continued positioning for future growth and preparing to meet the changing needs of the industry. , its consumers and the communities they serve.

“The breadth and depth of our leadership ensures that we are prepared to deliver on our promises to those we are privileged to serve and our commitment to promoting health beyond healthcare,” said Gail Boudreaux, President and CEO. “Collectively, these people are industry leaders dedicated to driving growth, change and innovation as we work to become a trusted lifelong health partner. “

The following changes come into effect on Tuesday, October 5:

  • Pete Haytaian will lead the diverse business group of Anthem and IngenioRx as Executive Vice-President and President, Diversified Affairs and IngenioRx. Most recently, Haytaian served as President of Commercial and Specialty, where over the past three years he has generated industry-leading growth, while responding to economic and market pressures, as well as ‘to uncertainty in the midst of the pandemic. Having also led Anthem’s government affairs division through transformative growth, Haytaian brings to this role an in-depth knowledge of Anthem’s healthcare industry and government and business operations and the potential of the company’s diverse businesses and businesses. pharmaceutical benefits.
  • Morgan kendrick will lead the business activities of Anthem, as Executive Vice-President and President, Commercial and Specialized Affairs Division, join the Anthem management team. Kendrick joined Anthem in 1995 and has been the driving force behind industry-leading innovation and growth in key areas of business activity, including in his roles as Chairman of National Accounts of Anthem and Chairman of Operations. business in Georgia. Kendrick has served as President of Western Commercial Markets since 2020, leading the performance, growth and strategic direction of Anthem’s business operations in California, Colorado, Indiana, Kentucky, Missouri, Nevada, Ohio and Wisconsin, as well as specialty sales through the company’s 14 local trade markets.
  • Rajeev ronanki had been named President, Digital Platforms, joining the Anthem management team. As the company accelerates its strategy to become a digital platform for healthcare, Ronanki will be responsible for developing and commercializing Anthem’s digital capabilities for consumers, healthcare providers and the healthcare ecosystem as the company strives to reinvent the delivery of care, operations and interactions. Since joining Anthem in 2018, Ronanki has led Anthem’s digital transformation by expanding our digitally-driven approach through our digital portfolios, artificial intelligence (AI), exponential technology, service experience and innovation.

About Anthem, Inc.

Anthem is a leading healthcare delivery company dedicated to improving lives and communities, and simplifying healthcare. Through its affiliates, Anthem serves more than 117 million people, including more than 44 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit or follow @AnthemInc on Twitter.

Forward-looking statements

This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views on future events and financial performance and are generally not historical facts. Words such as “expect”, “feel”, “believe”, “will”, “can”, “should”, “anticipate”, “intend”, “estimate”, “plan”, “Anticipate”, “plan” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, which could cause actual results to differ materially from those expressed, implied or projected by the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. You are also encouraged to carefully review and consider the various risks and other disclosures discussed in our reports filed from time to time with the United States Securities and Exchange Commission, which attempt to educate interested parties of factors that affect our activities. Except to the extent required by federal securities laws, we assume no obligation to republish any forward-looking statements revised to reflect events or circumstances subsequent to the date hereof. These risks and uncertainties include, but are not limited to: the impact of large-scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and disasters; trends in health care costs and utilization rates; our ability to secure sufficient premium rates, including regulatory approval and implementation of those rates; the impact of federal and state regulation, including ongoing changes to the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act 2010, as amended; changes in economic and market conditions, as well as regulations that may adversely affect our liquidity and investment portfolios; our ability to enter into contracts with suppliers on profitable and competitive terms; competitive pressures and our ability to adapt to changes in the industry and to develop and implement strategic growth opportunities; reduced registrations; the unauthorized disclosure of sensitive or confidential information of a member or employee, including the impact and outcome of any investigation, inquiry, complaint and dispute relating thereto; risks and uncertainties regarding Medicare and Medicaid programs, including those associated with failure to comply with complex regulations imposed on them; our ability to maintain and improve the Centers for Medicare and Medicaid Services star ratings and other funding quality and risk scores with respect to income earned from participation therein; a negative change in our mix of health products; costs and other liabilities associated with litigation, government investigations, audits or reviews; risks and uncertainties relating to our management of pharmacy benefits (“PBM”), including failure by any party to comply with the PBM services agreement between us and CaremarkPCS Health, LLC; claims for medical malpractice or professional liability or other risks relating to healthcare and PBM services provided by our subsidiaries; general risks associated with mergers, acquisitions, joint ventures and strategic alliances; changes in US tax laws; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in minimum required capital levels; our ability to repurchase shares of our common shares and to pay dividends on our common shares due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect of our substantial amount of outstanding debt; a deterioration in our financial strength ratings; the effects of any negative publicity relating to the healthcare industry in general or to us in particular; the inability to effectively maintain and modernize our information systems; events that could negatively affect our licenses with the Blue Cross and Blue Shield Association; the impact of international laws and regulations; intense competition to attract and retain employees; and various laws and provisions of our constating documents that may prevent or discourage takeovers and business combinations.

See the source version on

CONTACT: Investor Relations:

Stephane Tanal

[email protected] Media Relations:

Michelle vanstory

[email protected]



SOURCE: Anthem, Inc.

Copyright Business Wire 2021.

PUB: 05/10/2021 17: 00 / DISC: 05/10/2021 17:02

Copyright Business Wire 2021.

About John Tuttle

Check Also

Quit vaping programs are becoming essential for today’s workers

Vaping has become a growing concern in the workplace, with nearly 11 million American adults …

Leave a Reply

Your email address will not be published.